Skip to main content
Livermore
Livermore
ZHEN

Westpac Banking Corp

SEC CIK
0000719245
Latest filing
Aug 12, 2026

NBIX holding history

Neurocrine Biosciences Inc in every 13F filed by Westpac Banking Corp, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

NBIX overviewAll 13F holders of NBIXFull Q2 2026 holdings

Shares (Q2 2026)
0
Sold out in Q2 2026
Value
$0
% of portfolio
0.0%
Quarters held
21
Since Q1 2021
Holdings of NBIX by Westpac Banking Corp, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20260$00.0%−1,615−100.0%Sold outHolders
Q1 20261,615$212.8K<0.1%+91+6.0%AddedHolders
Q4 20251,524$216.1K<0.1%−6−0.4%ReducedHolders
Q3 20251,530$214.8K<0.1%−2,698−63.8%ReducedHolders
Q2 20254,228$531.4K<0.1%−56−1.3%ReducedHolders
Q1 20254,284$473.8K<0.1%−9,705−69.4%ReducedHolders
Q4 202413,989$1.91M0.1%+1,429+11.4%AddedHolders
Q3 202412,560$1.45M0.1%+6,170+96.6%AddedHolders
Q2 20246,390$879.7K0.1%−396−5.8%ReducedHolders
Q1 20246,786$935.9K0.1%00.0%UnchangedHolders
Q4 20236,786$894.1K0.1%+4,805+242.6%AddedHolders
Q3 20231,981$222.9K<0.1%−287−12.7%ReducedHolders
Q2 20232,268$213.9K<0.1%−4,828−68.0%ReducedHolders
Q1 20237,096$718.3K<0.1%00.0%UnchangedHolders
Q4 20227,096$847.5K<0.1%00.0%UnchangedHolders
Q3 20227,096$753.7K<0.1%00.0%UnchangedHolders
Q2 20227,096$691.7K<0.1%00.0%UnchangedHolders
Q1 20227,096$665.3K<0.1%00.0%UnchangedHolders
Q4 20217,096$604.4K<0.1%00.0%UnchangedHolders
Q3 20217,096$680.6K<0.1%00.0%UnchangedHolders
Q2 20217,096$690.6K<0.1%00.0%UnchangedHolders
Q1 20217,096$690.1K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.